Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
A7: This product is generally intended for healthy adults seeking weight management support
When used together, they can provide a stronger feeling of fullness, making it easier to stick to a lower-calorie diet
The current page also contains text that appears to describe a different product
Whilst all agents in this class can cause nausea, individual responses vary: Dulaglutide (Trulicity) is administered once weekly and some patients report fewer gastrointestinal effects Liraglutide (Victoza) requires daily injection but allows more gradual dose titration Exenatide (Byetta, Bydureon) is available in both short-acting (twice daily) and extended-release (once weekly) formulations Switching between GLP-1 agonists should be undertaken under medical supervision with appropriate dose adjustment and monitoring
